D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 79 Citations 18,475 267 World Ranking 10106 National Ranking 324

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Enzyme

Marcel M. Verbeek mainly investigates Alzheimer's disease, Pathology, Internal medicine, Cerebrospinal fluid and Dementia. His Alzheimer's disease research is multidisciplinary, incorporating elements of Amyloid beta, Pathogenesis and Degenerative disease. Pathology connects with themes related to Pericyte in his study.

His Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Oncology. His research in Cerebrospinal fluid intersects with topics in Protein S, Neurofilament, GFAP stain, Immunology and Dementia with Lewy bodies. His study in Dementia is interdisciplinary in nature, drawing from both Neurology, Cognition and Geriatrics.

His most cited work include:

  • CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. (893 citations)
  • Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study (469 citations)
  • Prediction of poor outcome within the first 3 days of postanoxic coma (442 citations)

What are the main themes of his work throughout his whole career to date?

Marcel M. Verbeek mostly deals with Pathology, Cerebrospinal fluid, Internal medicine, Disease and Alzheimer's disease. His research in Dementia, Cerebral amyloid angiopathy, Senile plaques, Amyloid beta and Dementia with Lewy bodies are components of Pathology. His Amyloid beta research includes themes of Pericyte and Perlecan.

The concepts of his Cerebrospinal fluid study are interwoven with issues in Multiple sclerosis, Immunology, Differential diagnosis, Biomarker and Atrophy. His work is dedicated to discovering how Internal medicine, Endocrinology are connected with Homovanillic acid and other disciplines. His Alzheimer's disease research is multidisciplinary, relying on both Degenerative disease and Amyloid.

He most often published in these fields:

  • Pathology (42.67%)
  • Cerebrospinal fluid (33.60%)
  • Internal medicine (31.73%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (31.73%)
  • Disease (24.80%)
  • Cerebrospinal fluid (33.60%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Internal medicine, Disease, Cerebrospinal fluid, Pathology and Biomarker. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Endocrinology and Oncology. His Disease research includes elements of Diagnostic accuracy, Neurology, Atrophy and Intensive care medicine.

His work carried out in the field of Cerebrospinal fluid brings together such families of science as Csf biomarkers, Central nervous system, Neuroinflammation, Neuroimaging and Biomarker discovery. His Cerebral amyloid angiopathy, Risk factor and Glial fibrillary acidic protein study, which is part of a larger body of work in Pathology, is frequently linked to Clinical Practice, bridging the gap between disciplines. Marcel M. Verbeek has included themes like Rotterdam Study, Amyloid β, Alzheimer's disease and Cognition in his Dementia study.

Between 2016 and 2021, his most popular works were:

  • Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis (154 citations)
  • Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia (82 citations)
  • The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice (81 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Disease

Disease, Internal medicine, Dementia, Biomarker and Cerebrospinal fluid are his primary areas of study. His Disease study incorporates themes from Gastroenterology, Neuroscience and Intensive care medicine. His work on Internal medicine is being expanded to include thematically relevant topics such as Endocrinology.

His biological study spans a wide range of topics, including White matter, Hyperintensity, Cognition, Alzheimer's disease and Neurology. His Biomarker research incorporates themes from Clinical neurochemistry, Multiple sclerosis, Clinical study design and Amyloid. Cerebrospinal fluid is a subfield of Pathology that Marcel M. Verbeek investigates.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

Niklas Mattsson;Henrik Zetterberg;Oskar Hansson;Niels Andreasen.
JAMA (2009)

1247 Citations

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study

Pieter Jelle Visser;Pieter Jelle Visser;Frans Verhey;Dirk L Knol;Philip Scheltens.
Lancet Neurology (2009)

720 Citations

Prediction of poor outcome within the first 3 days of postanoxic coma

E.G.J. Zandbergen;A. Hijdra;J. H.T.M. Koelman;A. A.M. Hart.
Neurology (2006)

681 Citations

Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury

P.E. Vos;K.J.B. Lamers;J.C.M. Hendriks;M. van Haaren.
Neurology (2004)

501 Citations

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

Niklas Mattsson;Ulf Andreasson;Staffan Persson;Hiroyuki Arai.
Alzheimers & Dementia (2011)

355 Citations

Glucose transporter-1 deficiency syndrome: The expanding clinical and genetic spectrum of a treatable disorder

Wilhelmina G. Leen;Joerg Klepper;Marcel M. Verbeek;Maike Leferink.
Brain (2010)

345 Citations

Prognosis of coma after therapeutic hypothermia: a prospective cohort study.

Aline Bouwes;Jan M. Binnekade;Michael A. Kuiper;Frank H. Bosch.
Annals of Neurology (2012)

336 Citations

CSF biomarker variability in the Alzheimer's Association quality control program

Niklas Mattsson;Niklas Mattsson;Ulf Andreasson;Staffan Persson;Maria C. Carrillo.
Alzheimers & Dementia (2013)

319 Citations

Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients.

K.J.B. Lamers;P.J.E. Vos;M.M. Verbeek;F. Rosmalen.
Brain Research Bulletin (2003)

292 Citations

Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta 1.

M. M. Verbeek;I. Otte-Höller;P. Wesseling;D. J. Ruiter.
American Journal of Pathology (1994)

279 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Marcel M. Verbeek

Henrik Zetterberg

Henrik Zetterberg

University of Gothenburg

Publications: 428

Kaj Blennow

Kaj Blennow

University of Gothenburg

Publications: 407

Philip Scheltens

Philip Scheltens

Vrije Universiteit Amsterdam

Publications: 138

Charlotte E. Teunissen

Charlotte E. Teunissen

Vrije Universiteit Amsterdam

Publications: 134

Pieter Jelle Visser

Pieter Jelle Visser

Maastricht University

Publications: 114

Wiesje M. van der Flier

Wiesje M. van der Flier

Vrije Universiteit Amsterdam

Publications: 97

Oskar Hansson

Oskar Hansson

Lund University

Publications: 92

Harald Hampel

Harald Hampel

Université Paris Cité

Publications: 91

John Q. Trojanowski

John Q. Trojanowski

University of Pennsylvania

Publications: 87

Niklas Mattsson

Niklas Mattsson

Lund University

Publications: 84

Leslie M. Shaw

Leslie M. Shaw

University of Pennsylvania

Publications: 81

Jens Wiltfang

Jens Wiltfang

University of Göttingen

Publications: 78

Frederik Barkhof

Frederik Barkhof

University College London

Publications: 76

Rik Ossenkoppele

Rik Ossenkoppele

Lund University

Publications: 63

Lucilla Parnetti

Lucilla Parnetti

University of Perugia

Publications: 60

Giovanni B. Frisoni

Giovanni B. Frisoni

University of Geneva

Publications: 57

Trending Scientists

Akira Isogai

Akira Isogai

University of Tokyo

Paitoon Tontiwachwuthikul

Paitoon Tontiwachwuthikul

University of Regina

Kirk S. Schanze

Kirk S. Schanze

The University of Texas Health Science Center at San Antonio

Jiannis Ragoussis

Jiannis Ragoussis

McGill University

Arthur Georges

Arthur Georges

University of Canberra

W. John Kress

W. John Kress

National Museum of Natural History

Samuel A. Cushman

Samuel A. Cushman

US Forest Service

David C. Hartnett

David C. Hartnett

Kansas State University

Mary Alice Coffroth

Mary Alice Coffroth

University at Buffalo, State University of New York

Claude B. Klee

Claude B. Klee

National Institutes of Health

David R. Morris

David R. Morris

University of Washington

Manuel Fresno

Manuel Fresno

Spanish National Research Council

F.J. Olmo

F.J. Olmo

University of Granada

André Luxen

André Luxen

University of Liège

Maryanne Martin

Maryanne Martin

University of Oxford

Stephen Graham

Stephen Graham

Newcastle University

Something went wrong. Please try again later.